03.04.2025
April 3rd, 2025 – L’Aigle - The IMV Technologies Group announces a change at the head of its company: as of April 1, 2025, Oliver Kohlhaas succeeds Alain de Lambilly as CEO of the IMV Technologies Group. Alain de Lambilly, who has successfully managed the company in recent years, is leaving the Group due to family reasons.
Joachim Hasenmaier, Chairman of the Supervisory Board, said: “We wholeheartedly thank Alain for his dedication and commitment to IMV Technologies and for the results and the quality of work he has accomplished together with the entire IMV Technologies organization. Under his leadership, IMV Technologies has taken decisive steps in its growth and transformation and has strengthened its position through both internal growth as well as several strategic acquisitions. We are convinced that Oliver Kohlhaas will continue this momentum, and that with the support and continued commitment of all IMV Technologies employees, he will continue to develop and successfully implement the company's strategy.”
Alain de Lambilly shared his thanks to the IMV Technologies customers and teams for the development and transformation of the company over the past few years: “I am proud of the progress we have made with our customers and all the IMV Technologies teams and of the successes we have achieved together. I wish Oliver every success for the future, and I am convinced that he will be able to lead the company with contagious commitment.”
Oliver Kohlhaas shared his enthusiasm: “I am delighted with this opportunity and approach this responsibility with confidence and energy. Together with the IMV Technologies employees, we will continue to develop the company to serve the current and future needs of our customers and to meet the challenges of a constantly changing world.”
Oliver Kohlhaas is German. He studied mathematics in Aachen and Bordeaux. After a few years in strategy consulting, he had a successful career spanning more than 20 years with the Bayer Group. He managed pharmaceutical activities in France and Germany, spent five years as Head of Global Marketing for the animal health business, before taking charge of corporate strategy and internal consulting for another five years. After leaving Bayer, he developed his own consulting business before joining IMV Technologies.
About the IMV TECHNOLOGIES Group
IMV Technologies is the world leader in animal assisted reproductive biotechnologies. Founded in 1963, IMV Technologies is a French company with subsidiaries and/or production sites in Brazil, China, Canada, France, India, the Netherlands, Scotland, Spain, Belgium, Sweden and the United States. IMV Technologies operates leading brands in the fields of semen analysis, assisted reproduction, artificial insemination and veterinary imaging. IMV Technologies' Life Sciences Business Unit, Cryo Bio System, manufactures and distributes equipment and supplies for human assisted reproduction and biobanks.
Contact:
Bruno PELTON - Bruno.pelton@imv-technologies.com
Group Chief Human Ressources Officer
